Printer Friendly

NIAID international research in infectious diseases (IRID) program (R01).

The National Institute of Allergy and Infectious Diseases (NIAID) encourages the submission of R01 applications from institutions in eligible foreign countries to conduct studies and establish collaborative infectious diseases research among investigators and institutions at international sites where NIAID has significant investment in research and/or infrastructure (see below for list of NIAID programs). These grants will serve to build independent research capacity by providing direct funding to investigators who do not currently have NIAIDfunded grant awards for research projects. The intent of these activities is to advance the development of local scientific expertise, build local research infrastructure, and increase collaborative research partnerships at NIAID international sites.

Collaborative projects involving investigators and institutions from international sites and the United States are particularly encouraged; a U.S. partner is not required. NIAID has a long-standing interest in and commitment to global health and international research. Topics of interest for this program are limited to research on infectious diseases, including emerging infections that are of the greatest public health significance within the applicant country (e.g., tuberculosis, malaria, HIV/AIDS, sexually transmitted diseases, diarrheal, respiratory, and enteric diseases, viral hemorrhagic fevers, viral encephalitides, parasitic diseases, and vector-borne diseases). Development of immunological, microbiological, biostatistical, epidemiological, and clinical research capacity is encouraged. Studies may be proposed on any aspect of infectious diseases (except clinical trials), including but not limited to the epidemiology, pathogenesis, immunopathogenesis of infectious diseases; epidemiologic studies to define the incidence, clinical presentations, and outcomes of diseases, identification of resistance patterns, characterization of susceptible cohorts for a particular pathogen; pilot and feasibility studies in preparation for larger studies.

NIAID supports a number of international research programs on infectious diseases, including HIV/AIDS. These include the International Centers of Excellence in Research (ICERs), International Collaborations for Infectious Disease Research (ICIDRs), the Tropical Medicine Research Centers (TMRCs), the Tuberculosis Research Program, the HIV Vaccine Trials Network (HVTN), and the HIV Prevention Trials Network (HPTN).

This International Research in Infectious Diseases (IRID) Program (R01) is intended to extend these programs by expanding the breadth of research supported at international sites and by providing support to new researchers. Applications from institutions in eligible countries where NIAID has significant investments through extramural research grants, cooperative agreements or contracts or through programs of the NIAID Division of Intramural Research are particularly encouraged. However, current NIH or NIAID funding is not a requirement.

Clinical trials will not be supported. When noninterventional clinical studies are a component of the research proposed, NIAID policy requires that studies be monitored commensurate with the degree of potential risk to study subjects and the complexity of the study. AN UPDATED NIAID policy was published in the NIH Guide on 8 July 2002 and is available at: grants/guide/notice-files/NOT-AI-02-032.html. The full policy, including terms and conditions of award, is available at ncn/pdf/clinterm.pdf).

This Funding Opportunity Announcement (FOA) will use the NIH Research Project Grant (R01) award mechanism.

The applicant will be solely responsible for planning, directing, and executing the proposed project.

This FOA uses "Just-in-Time" information concepts. It also uses the nonmodular budget formats (see modular/modular.htm). All foreign applicants must complete and submit nonmodular budget requests using the Research & Related Budget component found in the application package for this FOA. See NOT-OD-06-096, 23 August 2006.

At this time, it is not known if competing renewal (formerly "competing continuation") applications will be accepted and/or if this FOA will be reissued.

Applicants must download the SF424 (R&R) application forms and the SF424 (R&R) Application Guide for this FOA through

Note: Only the forms package directly attached to a specific FOA can be used. You will not be able to use any other SF424 (R&R) forms (e.g., sample forms, forms from another FOA), although some of the "Attachment" files may be useable for more than one FOA.

For further assistance, contact GrantsInfo: 301-435-0714 (telecommunications for the hearing impaired: TTY 301-451-0088) or by e-mail:

The application receipt dates for this PAR are 26 September 2007 and 2008. The complete version of this PAR is available at http://grants.nih. gov/grants/guide/pa-files/PAR-07-376.html.

Contacts: The complete list of agency contacts is available at pa-files/PAR-07-376.html. Reference: PAR-07-376.
COPYRIGHT 2007 National Institute of Environmental Health Sciences
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Fellowships, Grants, & Awards
Publication:Environmental Health Perspectives
Date:Sep 1, 2007
Previous Article:Advancing novel science in women's health research (ANSWHR) [R21].
Next Article:New books.

Related Articles
The forest for the trees: a systems approach to human health research.
Certified coffee does the premium Pay off?
Advancing novel science in women's health research (ANSWHR) [R21].
Cancer prevention research small grant program (R03).
Climate change and disability-adjusted life years.
Pennsylvania's Asthma School Project and descriptive pilot investigation: a focus on environmental health tracking and the outdoor air quality flag...
The Vessel Sanitation Program: government partnering with the cruise ship industry to improve public health.
U.S. EPA's Community Action for a Renewed Environment program and collaboration with CDC/ATSDR.
System to pinpoint airline passengers who contaminate cabins.
2007 NEHA's Annual Educational Conference & Exhibition: Atlantic City, New Jersey.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters